Korro Bio (KRRO) Stock: Buy, Sell, or Hold?
KRRO - Korro Bio, Inc. Common Stock
$9.64
-0.07 (-0.72%)
▼
5d:
+0.73%
30d:
-19.47%
90d:
-31.44%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When KRRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KRRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KRRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KRRO is currently trading at $9.64, which is considered oversold relative to its 30-day fair value range of $10.05 to $13.43.
Technical Outlook: Technically, KRRO is showing sideways momentum. Immediate support is located at $9.24, while resistance sits at $10.77.
Market Sentiment: KRRO scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.20 (+109.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KRRO is showing sideways momentum. Immediate support is located at $9.24, while resistance sits at $10.77.
Market Sentiment: KRRO scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.20 (+109.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.05 -
$13.43
Company Quality Score
68/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
95.8%
Protect Your Profits
Holding KRRO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (86/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 109.5% below Wall St target ($20.20)
- CAUTION: Bottoming setup, but lagging the sector by 31% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$10.05 -
$13.43
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.09
(11.3%)
Support & Resistance Levels
Support Level
$9.24
Resistance Level
$10.77
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.16
Wall Street Target
$20.20
(+109.5%)
Revenue Growth (YoY)
-43.1%
Share & Embed Analysis
Last updated: October 03, 2026 8:45 PM ET
Data refreshes hourly during market hours. Next update: 9:45 PM
Data refreshes hourly during market hours. Next update: 9:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRRO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
Advanced KRRO Option Strategies
Professional options setups generated by AI based on today's KRRO price and gamma walls.
